Snowball logo
logo
6000

China Resources Double-Crane Pharmaceutical Co Ltd

600062 SHG
¥18.29-¥0.09  (0.49%)
Start your journey to financial independence
Snowball will help you to track your portfolio, plan deposits to your brokerage account and increase passive income
Start

Frequently asked questions

What sector does China Resources Double-Crane Pharmaceutical Co Ltd (600062) operate in?

China Resources Double-Crane Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is China Resources Double-Crane Pharmaceutical Co Ltd (600062) current stock price?

As of the latest data, China Resources Double-Crane Pharmaceutical Co Ltd stock price is CN¥18.29, with a previous close of CN¥18.38. China Resources Double-Crane Pharmaceutical Co Ltd lost -CN¥0.09 in the last trading session, representing a -0.49% loss.

What is China Resources Double-Crane Pharmaceutical Co Ltd (600062) current market capitalization?

China Resources Double-Crane Pharmaceutical Co Ltd market cap is approximately 19.00 billion.

What is China Resources Double-Crane Pharmaceutical Co Ltd (600062) Earnings Per Share (EPS)?

The trailing EPS is CN¥1.57.

What is China Resources Double-Crane Pharmaceutical Co Ltd (600062) Price-to-Earnings (P/E) ratio?

China Resources Double-Crane Pharmaceutical Co Ltd current P/E ratio is 11.65.

Does China Resources Double-Crane Pharmaceutical Co Ltd (600062) pay dividends?

No. China Resources Double-Crane Pharmaceutical Co Ltd does not pay a dividend.

When is China Resources Double-Crane Pharmaceutical Co Ltd (600062) next earnings report?

China Resources Double-Crane Pharmaceutical Co Ltd is expected to release its next earnings report on March 31, 2025.

What is China Resources Double-Crane Pharmaceutical Co Ltd (600062) beta (volatility) score?

China Resources Double-Crane Pharmaceutical Co Ltd has a beta of 0.115, indicating lower volatility than the overall market.